Key result
Fetal cardiovascular biomarkers appear primarily fetal in origin, except MRproADM, establishing reference values for term neonates.
Why the study?
Several cardiovascular biomarkers have regulatory functions in perinatal physiology, but their feto-maternal distribution patterns and reference values at delivery were not established.
Cross-Sectional (n=189)
No
This study establishes reference values for key cardiovascular biomarkers in maternal and fetal compartments during full-term cesarean deliveries, indicating that most fetal biomarkers are of fetal origin.
Establishes feto-maternal biomarker reference values; leaves open clinical adoption pending prospective validation.
Background: Several cardiovascular biomarkers have regulatory functions in perinatal physiology. Aim: This study aimed to analyze the feto-maternal distribution pattern of biomarkers in samples of amniotic fluid, umbilical arterial blood, umbilical venous blood, and maternal blood samples, and to establish reference values. Each linked sample set consisted of the combined samples obtained in an individual pregnancy. Study design: We performed a prospective, observational, cross-sectional, single-center study. Subjects: The sample cohort included 189 neonates who were born to 170 mothers. A total of 162/189 neonates were full term and 129/189 were delivered by elective cesarean section. Outcome measures: Midregional pro-adrenomedullin (MRproADM [nmol/L]), midregional pro-atrial natriuretic peptide (MRproANP [pmol/L]), brain natriuretic peptide (BNP [pg/mL]), N-terminal pro-brain natriuretic peptide (NTproBNP [pg/mL]), copeptin [pmol/L], and high-sensitive troponin I (hsTnI [pg/mL]) levels were measured. Results: In singleton, full-term, primary cesarean deliveries (n=91), biomarker levels (median, [IQR]) at delivery were as follows. MRproADM levels in umbilical arterial blood/umbilical venous blood/amniotic fluid/maternal blood were 0.88 (0.20)/0.95 (0.18)/2.80 (1.18)/1.10 (0.54), respectively. MRproANP levels were 214.23 (91.38)/216.03 (86.15)/0.00 (3.82)/50.67 (26.81), respectively. BNP levels were 14.60 (25.18)/22.08 (18.91)/7.15 (6.01)/6.20 (18.23), respectively. NTproBNP levels were 765.48 (555.24)/816.45 (675.71)/72.03 (55.58)/44.40 (43.94), respectively. Copeptin levels were 46.17 (290.42)/5.54 (9.08)/9.97 (7.44)/4.61 (4.59), respectively. Levels of hsTnI were 6.20 (4.25)/5.60 (5.01)/0.45 (1.73)/2.50 (2.40), respectively. Conclusion: We determined reference values for biomarkers in term neonates delivered by primary cesarean section in amniotic fluid, umbilical arterial and venous blood, and maternal blood. Biomarkers in the fetal circulation appear to be of primary fetal origin, except for MRproADM.
No takes yet. Share an insight, caveat, or question.
Blohm et al. (2019) conducted a cross-sectional in Healthy term or late preterm pregnancies (n=189). Cardiovascular biomarkers (MRproADM, MRproANP, BNP, NTproBNP, copeptin, hsTnI) was evaluated on Feto-maternal distribution pattern and reference values of cardiovascular biomarkers in amniotic fluid, umbilical arterial blood, umbilical venous blood, and maternal blood. Cardiovascular biomarkers in the fetal circulation appear to be of primary fetal origin, except for MRproADM, with reference values successfully established for term neonates delivered by primary cesarean section.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: